Aeolus Pharmaceuticals Announces Successful Completion of Multiple
Dose Safety Study of AEOL 10150
LAGUNA NIGUEL, Calif.--(BUSINESS WIRE)--Mar 22, 2007 - Aeolus
Pharmaceuticals, Inc. (OTCBB:AOLS) announced today the successful
completion of the analysis of results from the Company's phase 1
multiple-dose study of
AEOL 10150 ("Study 102"). The clinical
direction for
AEOL 10150 is currently under ...
Aeolus Pharmaceuticals' AEOL 10150 Highlighted in Nature Genetics
Publication
LAGUNA NIGUEL, Calif.--(BUSINESS WIRE)--Apr 18, 2007 - Aeolus
Pharmaceuticals, Inc. (OTCBB:AOLS) announced today that a new
report published in the medical journal, Nature Genetics (Tong et
al. Nature Genetics 39:476-485, 2007), showed that Aeolus
Pharmaceuticals' lead compound
AEOL 10150 (MnTDEIP)...
Aeolus Pharmaceuticals' AEOL 10113 Demonstrates Potential as a
Protector of Healthy Normal Cells from Cancer Radiation Therapy
LAGUNA NIGUEL, Calif.--(BUSINESS WIRE)--Apr 19, 2007 - Aeolus
Pharmaceuticals, Inc. (OTCBB:AOLS) announced the presentation of
data by researchers at Loma Linda University Medical Center,
National Jewish Medical and Research Center and Duke University
showing that one of the Company's metalloporphy...
Aeolus Pharmaceuticals' AEOL 10113 May Play an Important Role
Regulating the Oxidative Damage Induced by Ionizing Radiation
LAGUNA NIGUEL, Calif.--(BUSINESS WIRE)--Apr 23, 2007 - Aeolus
Pharmaceuticals, Inc. (OTCBB:AOLS) announced the presentation of
data by researchers at Loma Linda University Medical Center showing
that one of the Company's metalloporphyrin antioxidants, AEOL
10113, may play an important role regulati...
Study Demonstrating Aeolus Compound's Neuroprotection in
Parkinson's Disease Published in the Journal of Neuroscience
...ny's first
orally available catalytic antioxidant,
aeol 11207, demonstrated
neuroprotection in an animal m...d has favorable blood-brain
barrier permeability.
aeol 11207 was tested for neuroprotection and oral
bio-...rin concentrations. The
researchers concluded that
aeol 11207 demonstrated neuroprotection
in the MPTP mou...